Search Results

Cilnivib M 10/50 - Cilnidipine 10 mg + Metoprolol 50 mg

CILNIVIB M 10/50

CILNIDIPINE 10mg. IP + METOPROLOL 50mg. IP

Send Enquiry

CURE

Tablets

Packaging and packing Type

Alu Alu | 10x10

MRP :

₹139

PTR :

₹105.9

PTS :

₹95.31

Combination of cilnidipine 10 mg and metoprolol 50 mg. Cilnidipine, a calcium channel blocker acting on L-type and N-type channels, relaxes the arter... Read More

Composition

CILNIDIPINE 10mg. IP + METOPROLOL 50mg. IP

Send Enquiry

Available on PCD franchise with monopoly rights: Cardiac and diabetic PCD franchise

India’s Trusted Pharma Brand

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

Combination of cilnidipine 10 mg and metoprolol 50 mg. Cilnidipine, a calcium channel blocker acting on L-type and N-type channels, relaxes the arteries and lowers blood pressure with little reflex rise in heart rate. Metoprolol, a cardioselective beta-1 blocker, slows the heart rate and reduces the force of heart contraction and renin release. The two lower blood pressure by different routes: cilnidipine by widening the arteries, metoprolol by reducing the work of the heart. Together they suit patients whose blood pressure is not controlled on one drug, particularly with a raised resting heart rate or coexisting angina. Metoprolol should not be stopped suddenly.

Side Effects

Tiredness, dizziness, headache, slow heart rate, cold hands and feet, flushing, ankle swelling, nausea, disturbed sleep., Less common: low blood pressure on standing, heart block, worsening of heart failure at the start of treatment, breathlessness or wheeze in patients with asthma, depression, sexual dysfunction; beta-blockers can mask the warning signs of low blood sugar in diabetics., Stopping metoprolol suddenly can worsen angina., Verapamil, diltiazem, digoxin, amiodarone and clonidine add to the slowing of heart rate., Not for use in heart rate below 50 per minute, second- or third-degree heart block, sick sinus syndrome, cardiogenic shock, decompensated heart failure, severe asthma, severe peripheral arterial disease or pregnancy.

Indication

Essential hypertension not controlled on monotherapy , Hypertension with raised resting heart rate , Hypertension with stable angina

For distributors and medical representatives

Cilnivib M 10/50 Tablet on PCD franchise

Cilnivib M 10/50 Tablet is part of Vibcare Pharma's cardiac and diabetic range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.

  • 1,500+products
  • Monopolyin your district
  • ₹20,000first order
  • Same-daydispatch

Cardiac and diabetic PCD franchisePCD pharma franchise with Vibcare

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Business Enquiry

Request a callback to get more information about becoming a Partner

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner

    Please enable JavaScript in your browser to complete this form.
    Do you have a Drug License?